ANI Pharmaceuticals shares rose Friday morning ... Adjusted earnings before interest, taxes, depreciation and amortization have also been revised higher to a range of $190 million to $200 million.

Zealand's stock jump suggested it could be acquired by Roche, and Zealand has been seen as a possible target, one shareholder told Reuters on condition of anonymity. "We have always said our ...

So with that we'll jump ... actually have to exceed that sort of an ROI threshold. So we do continue to look at it. We do engage with whether it's partners on the tech side or on the pharma ...

Patients with akathisia are known to jump off roofs ... This concludes the NRx Pharmaceuticals fourth quarter 2024 results conference call. Thank you all for participating and have a great day.

“We are building for a full launch in the normal pharma sense ... massive Q4 revenue jump—but it's not just thanks to Mounjaro and Zepbound Lilly figures it won't have to be conservative ...

Lexicon Pharmaceuticals, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its ...

X4 Pharmaceuticals, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall ...

New applications for benefits rose to 242,000 last week Claims in the US capital have been rising since start of year Applications for US unemployment benefits rose to the highest this year, amid an ...

Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims ...

Amman-based Hikma Pharmaceuticals Plc announced on Wednesday a 44 per cent jump in first-half profit helped by a strong performance at its US injectibles business, but the company cut its sales growth ...